Filing Flows › Comparisons › BBNX vs KMTS
Beta Bionics vs Kestra Medical Technologies: BBNX and KMTS compared
Beta Bionics is the larger company: $35.5M of revenue in its latest quarter (Q3 2026) against $31.0M for Kestra Medical Technologies (Q1 FY27). Kestra Medical Technologies is growing faster (+60% against +30% a year earlier). Beta Bionics is more profitable, with an operating margin of -74.9% against -121.6%.
Where the money goes: BBNX and KMTS
Beta Bionics (BBNX) · Q3 2026
Beta Bionics, Q3 2026: revenue $35.5M (+30% year over year), operating margin -74.9%, net loss $24.4M, operating cash flow −$12.3M. The chart follows the revenue to costs, profit and cash.
Kestra Medical Technologies (KMTS) · Q1 FY27
Kestra Medical Technologies, Q1 FY27: revenue $31.0M (+60% year over year), operating margin -121.6%, net loss $44.1M, operating cash flow −$32.3M. The chart follows the revenue to costs, profit and cash.
| Beta Bionics (BBNX) | Kestra Medical Technologies (KMTS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 FY27 |
| Revenue | $35.5M | $31.0M |
| Revenue growth, Y/Y | +30% | +60% |
| Operating margin | -74.9% | -121.6% |
| Net earnings | −$24.4M | −$44.1M |
| Net margin | -68.6% | -142.3% |
| Operating cash flow | −$12.3M | −$32.3M |
Questions
Which is bigger, Beta Bionics or Kestra Medical Technologies?
Beta Bionics is the larger company: $35.5M of revenue in its latest quarter (Q3 2026) against $31.0M for Kestra Medical Technologies (Q1 FY27).
Is Beta Bionics or Kestra Medical Technologies growing faster?
Kestra Medical Technologies is growing faster (+60% against +30% a year earlier).
Which is more profitable, Beta Bionics or Kestra Medical Technologies?
Beta Bionics is more profitable, with an operating margin of -74.9% against -121.6%.
More: Beta Bionics earnings · how Beta Bionics makes money · Kestra Medical Technologies earnings · how Kestra Medical Technologies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 27, 2026; 10-Q filed Sep 14, 2026). Fiscal quarters can end on different dates. Not investment advice.